诺瓦瓦克斯医药 NVAX 深 沪
已收盘 08-29 16:00:00 美东时间
7.47
-0.110
-1.45%
华盛通- 最 高7.79
- 今 开7.555
- 成交量 639.78万股
- 最 低 7.435
- 昨 收 7.58
- 总市值 12.10亿
- 52周最高 15.22
- 市盈率 静 --
- 换手率 3.95%
- 52周最低 5.01
- 委 比 64.27%
- 总股本 1.62亿
- 历史最高 331.68
- 量 比 0.75
- 振 幅 4.68%
- 历史最低 3.5324
- 每 手 1
- 风险率 1.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CDC vaccine advisory panel sets September meeting dates
The CDC's Advisory Committee on Immunization Practices (ACIP), which makes determinations on the segments of the population that should receive vaccinations, will next meet on Sept. 18 and Sept. 19. A...
08-29 01:47
HC Wainwright & Co. Assumes Novavax at Buy, Announces Price Target of $10
HC Wainwright & Co. analyst Sean Lee assumes Novavax (NASDAQ:NVAX) with a Buy rating and announces Price Target of $10.
08-28 18:47
Novavax Gains FDA Approval for Nuvaxovid Vaccine
Novavax ( ($NVAX) ) has issued an announcement. On August 27, 2025, Novavax ann...
08-28 04:58
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines
FDA approves Pfizer, Moderna, and Novavax Covid vaccines for high-risk groups as emergency authorizations end and vaccines transition to full marketing.
08-28 03:14
FDA Approves Novavax's Nuvaxovid For 2025–2026 Season As Only Protein-Based, Non-mRNA COVID-19 Vaccine In U.S.
Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination seasonGAITHERSBURG, Md., Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today
08-28 03:09
FDA authorizes updated Covid-19 shots, but with restrictions
The U.S. FDA has formally approved Covid-19 booster shots for the upcoming season, but unlike before, has placed significant restrictions on who is eligible for them. Those 65 and older, who are 65 an...
08-28 01:07
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'
The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a new vaccine task force led by a known skeptic.
08-26 02:31
Novavax Faces Stock Slump Amid Downgrade
Novavax ( ($NVAX) ) has fallen by -19.26%. Read on to learn why. Novavax has ex...
08-23 22:01
Ob-Gyns break with CDC to back COVID shots during pregnancy
The American College of Obstetricians and Gynecologists on Friday said it continues to recommend the use of COVID-19 vaccines during pregnancy, becoming the latest physician group to diverge from the ...
08-23 01:49
